Metraipolis › archive › dc_4fc0fa9d8ff8
Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination — Europe PMC PMID:40924614
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40924614
- DOI
- 10.1021/acschemneuro.5c00519
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T01:25:34.603Z
- SHA-256 of the archived text
7c73a7383897c887517effa40d9a0d162d26a54d15724ef03391e489842adc77- Stable URL of this page
https://metraipolis.com/documento/dc_4fc0fa9d8ff8
How to cite
Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination — Europe PMC PMID:40924614 — Europe PMC (en), https://europepmc.org/article/MED/40924614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fc0fa9d8ff8 (Metraipolis archive dc_4fc0fa9d8ff8, sha256 7c73a7383897c887517effa40d9a0d162d26a54d15724ef03391e489842adc77)
BibTeX
@misc{dc4fc0fa9d8ff8,
title = {Niraparib Demonstrates Therapeutic Potential in Multiple Sclerosis through Inhibition of IL-17A Receptor Interaction and Promotion of Remyelination — Europe PMC PMID:40924614},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40924614},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fc0fa9d8ff8; sha256 7c73a7383897c887517effa40d9a0d162d26a54d15724ef03391e489842adc77},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40924614. Agents can read the archived copy with the MCP tool read_document.